Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question

被引：7

作者：

Shimoni, A ^{[1
]}

Nagler, A ^{[1
]}

机构：

[1] Chaim Sheba Med Ctr, Dept Bone Marrow Transplantat, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel

来源：

LEUKEMIA | 2005年 / 19卷 / 06期

关键词：

D O I：

10.1038/sj.leu.2403771

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：891 / 893

页数：3

共 17 条

[1] The treatment of acute leukemia: past, present, and future [J].

Beutler, E .

LEUKEMIA, 2001, 15 (04) :658-661

[2] The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial [J].

Burnett, AK ;

Wheatley, K ;

Goldstone, AH ;

Stevens, RF ;

Hann, IM ;

Rees, JHK ;

Harrison, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) :385-400

[3] Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission [J].

Cassileth, PA ;

Harrington, DP ;

Appelbaum, FR ;

Lazarus, HM ;

Rowe, JM ;

Paietta, E ;

Willman, C ;

Hurd, DD ;

Bennett, JM ;

Blume, KG ;

Head, DR ;

Wiernik, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1649-1656

[4] Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation [J].

de Lima, M ;

Anagnostopoulos, A ;

Munsell, M ;

Shahjahan, M ;

Ueno, N ;

Ippoliti, C ;

Andersson, BS ;

Gajewski, J ;

Couriel, D ;

Cortes, J ;

Donato, M ;

Neumann, J ;

Champlin, R ;

Giralt, S .

BLOOD, 2004, 104 (03) :865-872

[5] Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS [J].

de Lima, M ;

Couriel, D ;

Thall, PF ;

Wang, XM ;

Madden, T ;

Jones, R ;

Shpall, EJ ;

Shahjahan, M ;

Pierre, B ;

Giralt, S ;

Korbling, M ;

Russell, JA ;

Champlin, RE ;

Andersson, BS .

BLOOD, 2004, 104 (03) :857-864

[6] Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].

Giralt, S ;

Estey, E ;

Albitar, M ;

vanBesien, K ;

Rondon, G ;

Anderlini, P ;

OBrien, S ;

Khouri, I ;

Gajewski, J ;

Mehra, R ;

Claxton, D ;

Andersson, B ;

Beran, M ;

Przepiorka, D ;

Koller, C ;

Kornblau, S ;

Korbling, M ;

Keating, M ;

Kantarjian, H ;

Champlin, R .

BLOOD, 1997, 89 (12) :4531-4536

[7] Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes [J].

Martino, R ;

Caballero, MD ;

Simón, JAP ;

Canals, C ;

Solano, C ;

Urbano-Ispízua, A ;

Bargay, J ;

Léon, A ;

Sarrá, J ;

Sanz, GF ;

Moraleda, JM ;

Brunet, S ;

San Miguel, J ;

Sierra, J .

BLOOD, 2002, 100 (06) :2243-2245

[8] Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects [J].

McSweeney, PA ;

Niederwieser, D ;

Shizuru, JA ;

Sandmaier, BM ;

Molina, AJ ;

Maloney, DG ;

Chauncey, TR ;

Gooley, TA ;

Hegenbart, U ;

Nash, RA ;

Radich, J ;

Wagner, JL ;

Minor, S ;

Appelbaum, FR ;

Bensinger, WI ;

Bryant, E ;

Flowers, MED ;

Georges, GE ;

Grumet, FC ;

Kiem, HP ;

Torok-Storb, B ;

Yu, G ;

Blume, KG ;

Storb, RF .

BLOOD, 2001, 97 (11) :3390-3400

[9] The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia:: a donor vs no donor comparison [J].

Mohty, M ;

de Lavallade, H ;

Ladaique, P ;

Faucher, C ;

Vey, N ;

Coso, D ;

Stoppa, AM ;

Gastaut, JA ;

Blaise, D .

LEUKEMIA, 2005, 19 (06) :916-920

[10] Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia:: disease status by marrow blasts is the strongest prognostic factor [J].

Sayer, HG ;

Kröger, M ;

Beyer, J ;

Kiehl, M ;

Klein, SA ;

Schaefer-Eckart, K ;

Schwerdtfeger, R ;

Siegert, W ;

Runde, V ;

Theuser, C ;

Martin, H ;

Schetelig, J ;

Beelen, DW ;

Fauser, A ;

Kienast, J ;

Höffken, K ;

Ehninger, G ;

Bornhäuser, M .

BONE MARROW TRANSPLANTATION, 2003, 31 (12) :1089-1095

← 1 2 →